chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving the vaccine I starting seeing stars then seen black, when I woke up I was sent to the ER. They scanned my brain and x-ray my elbow. Went to the follow up appointment where I was diagnosed with a concussion. I'm still off of work from the concussion.
tired; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An elderly female patient received BNT162b2 (COMIRNATY NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "tired".  Additional information: Nothing much other than it's difficult to run after having the vaccine because it makes patient tired. Patient considered event as caused by suspect product(s).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recvd vax 30MAR87 & in late APR87 was hospitalized w/viral encephalitis, EEG showed a mild non-specific abnormality w/no lateralizing features; unilateral dec use of an upper extremity; also had significant dec in speech, marked drooling
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients were vaccinated with the doses of improperly stored VAQTA lot # K009506, expiration date 22-SEP-2016, lot # K005958, expiration date 09-FEB-2017 (dose, route and site of administration were not reported). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested.
meningitis; headache; fever; weakness; rash; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (lot/batch number and expiration date not provided), via an unspecified route of administration, on 16Dec2020, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received the Pfizer-BioNTech COVID-19 Vaccine on 16Dec2020, he experienced headache, fever, weakness and rash; went to the ER and after testing blood work and suspecting of meningitis. They did a spinal tap. Test came out negative for Flu and COVID; was told the rash could be due to a drug reaction and they attributed side effects to a generic bactrim, so he stopped taking all medications. If he continues to have issues the primary concern is whether he should get the second dose of the COVID-19 vaccine or not. The outcome of the events were unknown.  Information on the lot/batch number has been requested.
Shortly after receiving the vaccine, I had a headache. Around 3am on Friday I had a fever, body aches, chills and still a terrible headache. Today is the 14th, 6 days after I received the vaccine and I still have a terrible headache which even prevents me from sleeping. I cannot explain the feeling of the headache, but it is terrible
syncope- several seconds after  immunization was administered. pt came too and i asked if he has passed out before and he stated every time he gets a shot and then passed out again, at which point his body made several "twitches". For safety I laid pt on the floor and propped his feet into a chair, Pt was coherent during the "leg-propping" stage. called 911 and informed of the situation. Pt laid on ground until EMT arrived. EMT "checked him out" and gave the all clear after he sits for 10 more minutes. Pt sat down in lobby for about 20 minutes then asked to leave which I told he could. He was lighthearted and jovial about the whole ordeal.
Systemic: Fainting / Unresponsive-Mild, Systemic: Seizure-Mild.
She received the quadrivalent, not Gardasil 9. I am submitting this form because I received a request to update information already provided through the online form. I was unable to find the "VAERS additional information request form," So I am providing the information (Lot number = unknown) by this form. Thanks!
HEART PALPITATIONS; ARM PAIN; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced heart palpitations, and arm pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the arm pain and heart palpitations was not reported. This report was non-serious.
Pt developed inflammation and 5 inch welt on 12/16 at the injection site. Pt went to Dr. on 12/17 and was prescribed doxycycline. Pt educated on possible injection site reactions with Covid-19 vaccines.
DAY OF SHOT-Throat felt tight, tongue tingled, dizziness, cold chills right after shot 03/11- I developed a dark red round ring underneath where I got the shot that has lasted for days. I googled and it stated it could be covid arm so I took antihistamines.
The vial experienced excursion in the refrigerator on 03OCT2022 with minimum temperature of 1.76 Celsius and maximum of 1.97 Celsius for 1 hour 40 minutes; No adverse event; Adult patient received Bivalent booster from vial that experienced excursion in the refrigerator on 03OCT2022; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Adult patient received Bivalent booster from vial that experienced excursion in the refrigerator on 03OCT2022), PRODUCT TEMPERATURE EXCURSION ISSUE (The vial experienced excursion in the refrigerator on 03OCT2022 with minimum temperature of 1.76 Celsius and maximum of 1.97 Celsius for 1 hour 40 minutes) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    In October 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In October 2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Adult patient received Bivalent booster from vial that experienced excursion in the refrigerator on 03OCT2022). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (The vial experienced excursion in the refrigerator on 03OCT2022 with minimum temperature of 1.76 Celsius and maximum of 1.97 Celsius for 1 hour 40 minutes) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Adult patient received Bivalent booster from vial that experienced excursion in the refrigerator on 03OCT2022), PRODUCT TEMPERATURE EXCURSION ISSUE (The vial experienced excursion in the refrigerator on 03OCT2022 with minimum temperature of 1.76 Celsius and maximum of 1.97 Celsius for 1 hour 40 minutes) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Adult patient received Bivalent booster from vial that experienced excursion in the refrigerator on 03OCT2022) and PRODUCT TEMPERATURE EXCURSION ISSUE (The vial experienced excursion in the refrigerator on 03OCT2022 with minimum temperature of 1.76 Celsius and maximum of 1.97 Celsius for 1 hour 40 minutes).    No concomitant information was reported. It was reported that excursion occurred in refrigerator on 03-Oct-2022 with minimum temperature of 1.76 Celsius and maximum of 1.97 Celsius for 1 hour 40 minutes. It was the first time the excursion occurred. It was reported that some of the vials were used and some were discarded. Reported that since 03OCT2022 (Excursion Date), 11 adult patients received booster doses from the Bivalent vials on 03OCT2022 and 05OCT2022. Treatment medications were not provided. This case was reported for patient 6 of 11 adult patients.
DEVELOPED  2 DVT'S IN RIGHT LEG. VERIFIED WITH DOPPPLER ULTRASOUND ON 9-29 . REPORT FROM DOPPLER IS AVAILABLE IF NEEDED. THE FIRST 2 MODERNA SHOTS WERE HERE AND BOOSTER ON SEPT 1 ST WAS IN ANOTHER STATE, AS WE LIVE THERE IN THE SUMMER. I AM CURRENTLY BEING TREATED BY HEMATOLOGIST AS LISTED ABOVE.
Twenty fours after second dose, tired and sore arm. I had like earache on Sept 2021. Saw doctor on September 05, 2021, Bell's Palsy. Still have the symptoms. Fully paralyzed on the right on the face. Felt paralyzed and pain in the ear and muscle spasms and feeling drastically better.  For 1st dose, it was administered incorrectly. My arm, my elbow and shoulder, I couldn't move for my elbow up.
Itchiness in the throat, using rescue inhaler.  Initially, then own breathing treatment.  10:41am  Client left site.  Verbalized that he feels much better.
Dizzy; nauseous; exhausted; soreness; This is a spontaneous report from a contactable consumer (patient).  A 50-year-old male patient, who is 50-year-old the date of vaccination, received bnt162b2 (BNT162B2), lot number: EL8982, via an unspecified route of administration on Arm Left, on 28Jan2021 12:00 as SINGLE DOSE (second dose) for COVID-19 immunization.  Medical history included High Blood Pressure. The patient received first dose of bnt162b2 (BNT162B2), lot number=EL3248, on 07Jan2021 at 12:00 on left arm. Concomitant medication included hydrochlorothiazide. On 28Jan2021 12:15, the patient experienced dizzy, nauseous, exhausted, soreness. The outcome of the events was not recovered. No treatment was received for the events. The patient did not have COVID prior vaccination. The patient was not tested post vaccination.
started with chills ,fever, than excessive fatigue, headache, muscle pain, and nausea
I started in the afternoon with a headache that progressed to a migraine headache that became severe and I contacted my neurologist who prescribed or suggested I take certain medications listed; Ubrelvy; Sumatriptan; Compazine. I still have  a migraine headache as this report is given.
sx pt shaking all over; documented t105; pt screaming & won't stop started @ approx 1620 called office @ 1625 instructed to seek ER 1935 given Advil
6-3-10 11:30 AM Admin PNEUMOVAX 23 10 pm tenderness under the arm. 6-4-10 2 AM fever 99.5 degrees F (Normal T was 96 degrees F) use cold towel only for fever. Rash as bumps on nose and around mouth. 3:30 AM Tightness of throat could not swallow cracker so drank milk and took BENADRYL 25 mg tab. 5 AM slept. 10:30 AM woke up felt better. 4:30 PM less arm tenderness and rash.
patient received a vaccine that had Expiration date Mar 06, 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021). On 10-Mar-2021, EXPIRED PRODUCT ADMINISTERED (patient received a vaccine that had Expiration date Mar 06, 2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.  On 10 March 2021 the vaccine was moved from freezer to refrigerator.   This case was linked to MOD-2021-307189 (Patient Link).
9 hrs after 2nd vaccine had 100.4 temp, chills, sore arm, sore throat, headache, runny nose and roof of my mouth felt raw and burned. After 24 hrs the chills, sore throat, raw burned mouth were gone.  Took Tylenol approx 33 hrs later for elevated temp. 48 hrs all symptoms were gone including sore arm.
Dehydration; Very weak; 8-10 hours of nausea and vomiting; 8-10 hours of nausea and vomiting; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (Dehydration), ASTHENIA (Very weak), NAUSEA (8-10 hours of nausea and vomiting), VOMITING (8-10 hours of nausea and vomiting) and FATIGUE (Very tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Cholesterol. Concomitant products included LOSARTAN for Blood pressure high, ATORVASTATIN CALCIUM (AVASTATIN) for High cholesterol.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jan-2021, the patient experienced DEHYDRATION (Dehydration), ASTHENIA (Very weak), NAUSEA (8-10 hours of nausea and vomiting), VOMITING (8-10 hours of nausea and vomiting) and FATIGUE (Very tired). The patient was treated with PARACETAMOL, PROMETHAZINE HYDROCHLORIDE (PHENARGAN PLUS) ongoing since an unknown date at a dose of 50 mg. On 01-Jan-2021, DEHYDRATION (Dehydration), ASTHENIA (Very weak), NAUSEA (8-10 hours of nausea and vomiting), VOMITING (8-10 hours of nausea and vomiting) and FATIGUE (Very tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medication included HRT. Reportedly the patient was able to hold broth, tea and biscuits. The next morning patient felt nice as if nothing had happened.   This case was linked to MOD-2021-079534 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Mar-2021: FUP obtained included: new events and concomitant medications.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events,  a causal relationship cannot be excluded.
Information has been received from a nurse concerning a 21 year old female with no past medical history who on 04-DEC-2006 was vaccinated with HPV (lot # 654510/0962F), intramuscularly. There was no concomitant medication. On 04-DEC-2006, "five hours after vaccination", the patient felt feverish plus experienced dizziness and nausea and diaphoretic. The patient went to bed that evening and the next morning symptoms had resolved. Unspecified medical attention was sought. Additional information has been requested.
I felt fine all day.   approximately 10 pm  I was ready for bed,  I suddenly started to get cold and was freezing.   Then felt a fever come on  then came the body aches.   I could not sleep all night,  my whole body was sore and achy.  I had a headache most of the next day.  I took 500mg acetaminophen 6 times that day.  It seemed like it did not help.  I was restless.  Went from bed to recliner.  Then about 8pm Saturday evening.  I took a shower and started to feel better.
A non-serious spontaneous report of given expired FLUMIST was received from a health professional concerning a eight-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The product expired on 05-Feb-2012. On 19-Feb-2012, the patient received expired FLUMIST. There was no adverse event associated with this medication error, therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age.
Started feeling itchy around her waist; Itchy on her arms; It turned into full body being red; Developed hives on upper arms; Later in the evening, she developed hives on upper legs; Red on her entire torso; It was very itchy and red around her neck; Red around neck.; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Started feeling itchy around her waist), PRURITUS (Itchy on her arms), ERYTHEMA (It turned into full body being red), URTICARIA (Developed hives on upper arms) and URTICARIA (Later in the evening, she developed hives on upper legs) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PRURITUS (Started feeling itchy around her waist), PRURITUS (Itchy on her arms), ERYTHEMA (It turned into full body being red), URTICARIA (Developed hives on upper arms), URTICARIA (Later in the evening, she developed hives on upper legs), ERYTHEMA (Red on her entire torso), PRURITUS (It was very itchy and red around her neck), ERYTHEMA (Red around neck.) and RASH (Rash). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Started feeling itchy around her waist), PRURITUS (Itchy on her arms), ERYTHEMA (It turned into full body being red), URTICARIA (Developed hives on upper arms), URTICARIA (Later in the evening, she developed hives on upper legs), ERYTHEMA (Red on her entire torso), PRURITUS (It was very itchy and red around her neck), ERYTHEMA (Red around neck.) and RASH (Rash) had resolved. Not Provided          No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.
Right arm erythematous, increased skin temp, mild tenderness at upper arm. Benadryl.
Information has been received from a nurse concerning a 16 year old female who sometime in October 2007, was vaccinated with the first dose of Gardasil (lot number not reported). Concomitant therapy included SINGULAIR, VENTOLIN and ZYRTEC. In October 2007, the patient experienced losing her hair and was diagnosed with "alopecia ariat". On an unspecified date the patient has received the second dose of Gardasil (lot number not reported). The patient is still experiencing hair loss and currently receives steroid injections in her head every six weeks. No further information is available.
Within 1 hour, employee started to feel itchy. Pain at injection site. Rash started with small open areas. Prednisone to start on 11/12/05. MRI to be done to assess nerve damage. Left upper arm slightly swollen. Feels squeezing type discomfort. No pain medication needed.
TIC received from clients father stating that pt. formed a rash thru the night.  States that she has small red bumps on bilat forearms, hands & L thigh, reports no fever, reports itching.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, the patients were inadvertently vaccinated with the improperly stored doses PEDVAXHIB (lot # M011814 with expiration date 15-OCT-2018; dose and route of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted.
This spontaneous report as received from a registered nurse referring to a 14 year old female patient. On 26-MAY-2017 the patient was vaccinated with GARDASIL lot # L035105 for prophylaxis. On 26-MAY-2017, the patient experienced expired product administered. On an unknown date the patient experienced no adverse event. The outcome of expired product administered and no adverse event is unknown. The reporter considered expired product administered and no adverse event to be not related to GARDASIL. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1707USA006834.
Cramping in hips for 1 week, bilateral cramps and pain in hips and back. Cramping in right leg behind knee, felt hard to touch.
Information has been received on 19-DEC-2018 regarding a case in litigation from a lawyer concerning a male patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 22-APR-2008, a healthcare provider at a clinic administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 18-NOV-2016, the patient was treated by a physician at a hospital for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages.The outcome of the events is not recovered. The causality of the events is related. Additional information has been requested.
Information has been received from a nurse practitioner concerning a 2 month old male who was vaccinated PO with the first dose of Rotateq (Lot #655296/0979F). Concomitant therapy included PedvaxHIB and Pediarix. Subsequently the patient experienced explosive diarrhea. The physician changed the formula and sent the patient to the emergency room. The physician is going to follow up but did not know the patient's current state at the time of the report. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested. Follow-up information was received from the NP concerning the 10-week-old male with no medical history who on the morning of 21-JUN-2007 was vaccinated PO with the first dose of ROTATEQ (lot # 635296/0979P). There was no illness at time of vaccination. The NP reported that on 02-JUL-2007, at 1547, the patient developed loose, watery, explosive diarrhea 10 x/day until 06-JUL-2007. No laboratory/diagnostic tests were performed. The patient's formula was changed to soy formula x 2 weeks with no further evaluation or illness reported. Additional information is not expected.
Leukonychia developed by 9 pm near the distal end of all 10 fingernails. Really strange. I had the Pfizer booster shot today. My second vaccination was on April 2, 2021, which is why I had the booster.
Rash. Loratadine 10 mg every day, ranitidine 150 mg every day.